Dr. Roxanne Dryden-Edwards is an adult, child, and adolescent psychiatrist. She is a former Chair of the Committee on Developmental Disabilities for the American Psychiatric Association, Assistant Professor of Psychiatry at Johns Hopkins Hospital in Baltimore, Maryland, and Medical Director of the National Center for Children and Families in Bethesda, Maryland.
Melissa Conrad Stöppler, MD, is a U.S. board-certified Anatomic Pathologist with subspecialty training in the fields of Experimental and Molecular Pathology. Dr. Stöppler's educational background includes a BA with Highest Distinction from the University of Virginia and an MD from the University of North Carolina. She completed residency training in Anatomic Pathology at Georgetown University followed by subspecialty fellowship training in molecular diagnostics and experimental pathology.
Addington, A.M., M. Gornick, J. Duckworth, et al. "GAD1 (2q31.1), which encodes
glutamic acid decarboxylase (GAD-67), is associated with childhood onset
schizophrenia and cortical gray matter volume loss." Molecular Psychiatry 10 (2005): 581-588.
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition. Washington, D.C.: American Psychiatric Association, 2013.
American Psychiatric Association. Diagnostic and Statistical Manual of Mental
Disorders, Fourth Edition, Text Revision; Washington, D.C.: American Psychiatric Association, 2000.
Baker, F.M., and C.C. Bell. "Issues in the psychiatric treatment of African Americans."
Psychiatric Services 50 Mar. 1999: 362-368.
Beresford, C., S. Hepburn, and R.G. Ross. "Follow-up for 6 and 8 years." Clinical Child
Psychology and Psychiatry 10 (2005): 429-439.
Brisch, R., A. Saniotis, R. Wolf, et al. "The role of dopamine in schizophrenia from a neurobiological and evolutionary perspective: old fashioned, but still in vogue." Frontiers in Psychiatry May 2014.
Bond, G. "Assertive community treatment for people with severe mental illness."
Indiana University-Purdue University Indianapolis Mar. 2002. Indianapolis,
Cascade, E.F., A.H. Kalali, and P.F. Buckley. "Current management of schizophrenia:
Antipsychotic monotherapy versus combination therapy." Psychiatry 5.5 May 2008:
Chanpattanaa, W., and M.L.S. Chakrabhandb. "Combined ECT and neuroleptic therapy in
treatment-refractory schizophrenia: prediction of outcome." Psychiatry Research 105.1 Dec.
Chobanian, A.V., G.L. Bakris, H.R. Black, et al. "The seventh report of the Joint National Committee on prevention, detection, evaluation and treatment of high blood pressure: the JNC 7 report." Journal of the American Medical Association 289.19 (2003): 2560-2572.
Davies, E.J. "Developmental aspects of schizophrenia and related disorders: possible implications for treatment strategies." British Journal of Psychiatry Aug. 2007.
Dixon, L., D. Perkins, and C. Calmes. "Guideline Watch: Practice Guideline for the
Treatment of Patients With Schizophrenia." PsychiatryOnline.com. Sept. 2009. <http://www.psychiatryonline.com/content.aspx?aid=501001>.
Fitzgerald, M. "Schizophrenia and autism/Asperger’s syndrome: overlap and difference." Clinical Neuropsychiatry 9.4 (2012): 171-176.
Friedman, J.I., T. Vrijenhoek, S. Markx, et al. "CNTNAP2 gene dosage variation is associated with schizophrenia and epilepsy." Molecular Psychiatry 13 Mar. 2008: 261-266.
Gabrovsek, V.P. "Inpatient group therapy of patients with schizophrenia." Psychiatria Danubina 21.1 (2009): 67-72.
Gentile, S. "Antipsychotic therapy during early and late pregnancy. A systemic
review." Oxford University Press, 2008.
Hedgecoe, A. "Schizophrenia and the narrative of enlightened geneticazation."
Social Studies of Science 31 (2001): 875.
Hollis, C. "Developmental precursors of child- and adolescent-onset
schizophrenia and affective psychoses: diagnostic specificity and continuity
with symptom dimensions." The British Journal of Psychiatry 182 (2003): 37-44.
Husseini, A., and D. Gianakos. "The 15-minute visit." Patient Care 40 (2006): 9-10.
Jablensky, A.V., V. Morgan, S.R. Zubrick, C. Bower, et al. "Pregnancy, delivery and neonatal complications in a population cohort of women with schizophrenia and major affective disorders." Am J Psychiatry 162.1 Jan. 2005: 79-91.
Khorrami, S. "Genius, madness, and masculinity: A beautiful mind examined
through a men's issue model." Men and Masculinities 5 (2002): 116.
Kyziridis, T.C. "Notes on the history of schizophrenia." German Journal of
Psychiatry 8 (2005): 42-48.
Leucht, S., C. Corves, D. Arbter, et al. "Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis." Lancet 373 (2009): 31-41.
Lin, K.M, and F. Cheung. "Mental health issues for Asian Americans." Psychiatric
Services 50 June 1999: 774-780.
Marin, H. "Hispanics and psychiatric medications: An overview." Psychiatric
Times 20.10 Oct. 2003.
Mattai, A.K., J.L. Hill, and R.K. Lenroot. "Treatment of early onset schizophrenia."
Current Opinion in Psychiatry 23 July 2010.
McGrath, J., S. Saha, D. Chant, and J. Welham. "Schizophrenia: A concise overview of
incidence, prevalence and mortality." Epidemiologic Reviews 30.1 (2008): 67-76.
McGurk, S.R., K.T. Mueser, P.D. Harvey, et al. "Cognitive and symptom predictors of
work outcomes for clients with schizophrenia in supported employment."
Psychiatric Services 54 Aug. 2003: 1129-1135.
Meador-Woodruff, J.H., and J.E. Kleinman. "Neurochemistry of Schizophrenia: Glutamatergic Abnormalities." Neuropsychopharmacology: The Fifth Generation of Progress, Fifth Ed. Ed. Kenneth L. Davis, Dennis Charney, Joseph T. Coyle, and Charles Nemeroff. Philadelphia, Pa.: Lippincott, Williams & Wilkins, 2002: 717-728.
Meltzer, H.Y. "Clozapine: balancing safety with superior antipsychotic efficacy." Clinical Schizophrenia and Related Psychoses Oct. 2012: 134-144.
Meyer, I.H. "Prejudice, social stress and mental health in lesbian, gay and
bisexual populations: conceptual issues and research evidence." Psychological
Bulletin 129.5 (2003): 674-697.
Mingoia, G., G. Wagner, K. Langbein, et al. "Default mode network activity in schizophrenia studied at resting state using probabilistic ICA." Schizophrenia Research 2012: 1-7.
Pfister, R.D. "Teenagers' media consumption and perception of mental illness." American University, Washington, D.C. 2014.
President and Fellows of Harvard College. "Schizophrenia and Bipolar Disorder May Share Genetic Origins." Harvard Mental Health Lett 25.12 June 2009: 7.
Read, J., and R. Bentall. "Schizophrenia and childhood adversity." American Journal of
Psychiatry 167 June 2010: 717-718.
Ross, R.G. "Psychotic and manic-like symptoms during stimulant treatment of attention deficit hyperactivity disorder." American Journal of Psychiatry 163.7 (2006): 1149-1152.
Schultze-Lutter, F. "Subjective symptoms of schizophrenia in research and the clinic: The basic symptom concept." Schizophrenia Bulletin 35.1 Jan. 2009: 5-8.
Semple, D.M., A.N. McIntosh, and S.M. Lawrie. "Cannabis as a risk factor for psychosis: systemic review." Journal of Psychopharmacology 19 (2005): 187.
Sorensen, H.J., E.L. Mortensen, J.M. Reinisch, and S.A. Mednick. "Association between prenatal exposure to bacterial
infection and risk of schizophrenia." Schizophrenia Bulletin 35.3 May 2009:
Veling, W., E. Susser, J. van Os, J.P. Mackenbach, et al. "Ethnic density of
neighborhoods and incidence of psychotic disorders among immigrants." American
Journal of Psychiatry Dec. 2007: 1-8.
Velligan, D.I., and L.D. Alphs. "Negative symptoms in schizophrenia: the importance of
identification and treatment." Psychiatric Times 25.3 Mar. 2008.
Volkow, N.D. "Substance use disorders in schizophrenia: Clinical implications of
comorbidity." Schizophrenia Bulletin 35.3 May 2009: 469-472.
Wasserman, S., A. Weisman de Mamani, and P. Mundy. "Parents' criticisms and
attributions about their adult children with high functioning autism or
schizophrenia." Autism 14 (2010): 127-138.
Woodberry, K.A., A.J. Giuliano, and L.J. Seidman. "Premorbid IQ in schizophrenia: a meta-analytic review." American Journal of Psychiatry 165 (2008): 579-587.